Alessio Fusco

Understanding how older age drives decision‐making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients

M. B. Bacchi Reggiani, N. Vianelli, M. Cavo, 2018, British journal of haematology.

Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study

E. Zamagni, V. De Stefano, P. Tosi, 2021, Leukemia & lymphoma.

Role of serum‐free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma

E. Zamagni, N. Testoni, M. Cavo, 2022, American journal of hematology.

Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma

E. Borsi, E. Zamagni, N. Testoni, 2020, Bone Marrow Transplantation.